371 related articles for article (PubMed ID: 27590129)
1. T-cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation.
Stephenson E; Savvatis K; Mohiddin SA; Marelli-Berg FM
Br J Pharmacol; 2017 Nov; 174(22):3914-3925. PubMed ID: 27590129
[TBL] [Abstract][Full Text] [Related]
2. Targeting inflammation to reduce cardiovascular disease risk.
Maffia P; Cirino G
Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.
Kyaw T; Peter K; Li Y; Tipping P; Toh BH; Bobik A
Br J Pharmacol; 2017 Nov; 174(22):3956-3972. PubMed ID: 28471481
[TBL] [Abstract][Full Text] [Related]
4. Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.
Sage AP; Mallat Z
Br J Pharmacol; 2017 Nov; 174(22):3926-3939. PubMed ID: 28052311
[TBL] [Abstract][Full Text] [Related]
5. Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?
Welsh P; Grassia G; Botha S; Sattar N; Maffia P
Br J Pharmacol; 2017 Nov; 174(22):3898-3913. PubMed ID: 28409825
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory dilated cardiomyopathy (DCMI).
Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
[TBL] [Abstract][Full Text] [Related]
7. Role of impaired central tolerance to α-myosin in inflammatory heart disease.
Lv H; Lipes MA
Trends Cardiovasc Med; 2012 Jul; 22(5):113-7. PubMed ID: 22902177
[TBL] [Abstract][Full Text] [Related]
8. Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis.
Foks AC; Kuiper J
Br J Pharmacol; 2017 Nov; 174(22):3940-3955. PubMed ID: 28369782
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system.
Cirino G; Vellecco V; Bucci M
Br J Pharmacol; 2017 Nov; 174(22):4021-4031. PubMed ID: 28407204
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling 1 DNA administration inhibits inflammatory and pathogenic responses in autoimmune myocarditis.
Tajiri K; Imanaka-Yoshida K; Matsubara A; Tsujimura Y; Hiroe M; Naka T; Shimojo N; Sakai S; Aonuma K; Yasutomi Y
J Immunol; 2012 Aug; 189(4):2043-53. PubMed ID: 22798678
[TBL] [Abstract][Full Text] [Related]
11. [Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy].
Pauschinger M; Kühl U; Dörner A; Schieferecke K; Petschauer S; Rauch U; Schwimmbeck PL; Kandolf R; Schultheiss HP
Z Kardiol; 1998 Jun; 87(6):443-52. PubMed ID: 9691414
[TBL] [Abstract][Full Text] [Related]
12. Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy.
Zhao L; Fu Z
J Immunol Res; 2018; 2018():5301548. PubMed ID: 29854842
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Autoimmunity: Myocarditis.
Bracamonte-Baran W; Čiháková D
Adv Exp Med Biol; 2017; 1003():187-221. PubMed ID: 28667560
[TBL] [Abstract][Full Text] [Related]
14. Genetically determined myocarditis: clinical presentation and immunological characteristics.
Caforio AL; Iliceto S
Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of cardiac inflammation: molecular mechanisms.
Pankuweit S; Portig I; Maisch B
Herz; 2002 Nov; 27(7):669-76. PubMed ID: 12439638
[TBL] [Abstract][Full Text] [Related]
16. Inflammation in dilated cardiomyopathy.
Pankuweit S; Ruppert V; Maisch B
Herz; 2004 Dec; 29(8):788-93. PubMed ID: 15599676
[TBL] [Abstract][Full Text] [Related]
17. Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.
Woodward L; Akoumianakis I; Antoniades C
Br J Pharmacol; 2017 Nov; 174(22):4007-4020. PubMed ID: 27629236
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell and T-cell crosstalk: Targeting metabolism as a therapeutic approach in chronic inflammation.
Certo M; Elkafrawy H; Pucino V; Cucchi D; Cheung KCP; Mauro C
Br J Pharmacol; 2021 May; 178(10):2041-2059. PubMed ID: 31999357
[TBL] [Abstract][Full Text] [Related]
19. Role of immune cells in hypertension.
Caillon A; Paradis P; Schiffrin EL
Br J Pharmacol; 2019 Jun; 176(12):1818-1828. PubMed ID: 29952002
[TBL] [Abstract][Full Text] [Related]
20. Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.
Iqbal F; Baker WS; Khan MI; Thukuntla S; McKinney KH; Abate N; Tuvdendorj D
Br J Pharmacol; 2017 Nov; 174(22):3986-4006. PubMed ID: 28326542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
